William D Schwieterman's Net Worth
-$83.3 Thousand
Who is William D Schwieterman?
William D Schwieterman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MATEON THERAPEUTICS INC, and Chelsea Therapeutics International, Ltd..
SEC CIK
William D Schwieterman's CIK is 0001403961
Past Insider Trading and Trends
2009 was William D Schwieterman's most active year for acquiring shares with 13 total transactions. William D Schwieterman's most active month to acquire stocks was the month of December. 2017 saw William D Schwieterman paying a total of $206,250.00 for 550,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MATEON THERAPEUTICS INC (OTLC) Snapshot price: $0.03975
President and CEOWilliam D Schwieterman owns 625,747 units of Common Stock which is worth $24,873.44 and 179,208 units of Common Stock, $0.01 par value per share which is worth $7,123.52. From 2007 to 2018 William D Schwieterman acquired a total of 804,208 shares in MATEON THERAPEUTICS INC at a cost of $115,346.63.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +83,668.01% | 625K |
—
|
—
| 625.75K |
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| +16.21% | 25K |
$0.23 | $5,750.00 | 179.21K |
Jan 2
| |||
Form 4
| +19.35% | 25K |
$0.38 | $9,502.50 | 154.21K |
Jul 1
| |||
Form 4
| +48.19% | 42.02K |
$1.14 | $47,899.38 | 129.21K |
Dec 31 - Jan 2
| |||
Form 4
| +52.46% | 30K |
$1.14 | $34,200.00 | 87.19K |
Dec 8
| |||
Form 4
| +5.87% | 3.17K |
$1.42 | $4,499.98 | 57.19K |
Sep 30
| |||
Form 4
| +35.06% | 14.02K |
$0.96 | $13,494.77 | 54.02K |
Jan 20 - Jun 30
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chelsea Therapeutics International, Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||